Atorvia graduates from SheBoot, a women-led program for women-led businesses.

Residency & programming at the University of Toronto’s new wet lab facility, a generous cash prize and a year of mentoring by Merck will allow Atorvia to accelerate development of a first-in-class treatment for kidney failure.

Atorvia wins the Johnson and Johnson award for Biotechnologies and Biopharmaceuticals at Effervescence 2024.

Atorvia graduates from Creative Destruction Labs, Berlin Health Stream.

Atorvia selected by OBio for inaugural 2023/24 Women in Health initiative seed program.